Viewing nowCombinationDispozigen 5/160mg
Valsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.

MFDS item code 201309050 · Approved 2013.08.29 · Insurance code 678600240
Treatment of essential hypertension not controlled with monotherapy
This medication effectively lowers blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy with either amlodipine or valsartan. This is because the two drugs act through different mechanisms, enhancing the blood pressure-lowering effect. Therefore, this drug is used to improve blood pressure control in hypertensive patients who do not respond adequately to monotherapy.
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended that the medication be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medication. However, if blood pressure is not adequately controlled with monotherapy using either component, switching directly to this medication may be considered as follows. ㆍ5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. ㆍ5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. ㆍ10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients taking valsartan and amlodipine concomitantly may switch to this medication (a combination product containing the same amount of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medication should not be used in patients with severe renal impairment (creatinine clearance less than 10mL/min) or in patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medication to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Adults 65 years of age or older: Use caution when increasing the dose.
The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus and newborn during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It is not safe to use in patients with allergies to any ingredients of this drug, pregnant or nursing women, and patients with severe kidney or liver dysfunction. Hypotension may occur in patients with sodium or fluid depletion, so it is essential to manage their condition before administration and to closely monitor them during treatment. Patients with high potassium levels or kidney dysfunction should frequently check their potassium levels when taking this medication along with potassium supplements, etc. Patients with a history of kidney transplantation or angioedema require special caution when using this drug, and treatment should be stopped immediately if angioedema occurs. Patients with heart failure or myocardial infarction may experience changes in kidney function, thus regular testing is necessary, requiring caution in administration. This medication may cause dizziness or fatigue, necessitating caution when driving or operating machinery. Furthermore, this drug may interact with other antihypertensives, potassium-sparing diuretics, non-steroidal anti-inflammatory drugs (NSAIDs), so consultation with a physician or pharmacist is essential if other medications are being taken. Women who are pregnant or planning to become pregnant and nursing mothers should avoid taking this drug and consult a physician when planning pregnancy. The safety and efficacy in pediatric patients under 18 years of age have not been sufficiently established, so use is not recommended. In case of overdose, hypotension or heart-related issues may occur, so it is crucial to adhere to the prescribed dosage and visit a medical facility immediately if abnormal symptoms appear.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, rash, itching, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial edema, generalized edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory loss, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorder, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuropathic irritation, sensory loss, Stevens-Johnson syndrome, headache, dizziness, itching, peripheral edema, hypotension, edema, chest pain, pain, cough, nocturnal enuresis
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to avoid contact with air or moisture. It is important to keep the storage temperature between 1 and 30 degrees Celsius at room temperature.
Dark yellow egg-shaped film-coated tablet
PTP - 28 tablets/box[(14 tablets/PTP pack × 2)], bottle - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.